Clinical Trial Update: Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating a combination of immunotherapy and radiation for resectable soft tissue sarcoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Immunotherapy + Radiation

Snippet

Sponsor: University of Rochester | Conditions: Sarcoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING